{"version":"1.0","provider_name":"MedCity News","provider_url":"https:\/\/medcitynews.com","author_name":"Frank Vinluan","author_url":"https:\/\/medcitynews.com\/author\/fvinluan\/","title":"VC Firm Kurma Partners Closes \u20ac215M Fund in Pursuit of \u2018Disruptive Therapeutic Solutions\u2019 - MedCity News","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"oLJdUC3bW0\"><a href=\"https:\/\/medcitynews.com\/2026\/04\/kurma-partners-fund-venture-capital-biotech-investing-startups-europe\/\">VC Firm Kurma Partners Closes \u20ac215M Fund in Pursuit of \u2018Disruptive Therapeutic Solutions\u2019<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/medcitynews.com\/2026\/04\/kurma-partners-fund-venture-capital-biotech-investing-startups-europe\/embed\/#?secret=oLJdUC3bW0\" width=\"600\" height=\"338\" title=\"&#8220;VC Firm Kurma Partners Closes \u20ac215M Fund in Pursuit of \u2018Disruptive Therapeutic Solutions\u2019&#8221; &#8212; MedCity News\" data-secret=\"oLJdUC3bW0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2019\/06\/ParisEiffel-e1561146081131.jpg","thumbnail_width":700,"thumbnail_height":467,"description":"Kurma Partners\u2019 new fund is the venture capital firm\u2019s fourth and largest. Previous Kurma investments have led to exits that include the acquisitions of Corlieve Therapeutics, Emergence Therapeutics, and Amolyt Pharma."}